Senior ML Scientist - Molecular AI

About the Site

Our Research & Development organization brings together the best minds in life science innovation. The teams located in facilities in Lexington, Watertown, and Cambridge reflect the full R&D continuum, from early research through late-stage clinical development. Here, we are building for the future, creating a distinct R&D community based on collaboration, partnerships, and cutting‑edge research across multiple modalities and therapeutic areas.

We recognize that improving human health starts here Cesarina. The patient relies on us. Our R&D hub merges biotech speed and agility with large pharmaceutical company quality, resources, and stability, uniting the best of both worlds to develop new medicines for patients.

The Molecular AI (MolAI) team is part of Novo Nordisk’s AI and Digital Innovation (ADI) area where we apply and develop state of the art capabilities in predictive science, AI/ML and structure‑based drug design. Scientists within MolAI collaborate seamlessly with teams across the globe to invent better molecules faster. With an unbiased approach to drug modalities, in‑house access to the newest screening techniques, and(non‑HD) world‑class experimentation, we have a wealth of opportunities to impact fingerprint and pipeline and ultimately save and improve patient lives.

We work in multidisciplinary, highly collaborative discovery teams both locally and across Novo Nordisk’s global network Grafik, to invent novel medicines by applying advanced computational techniques and developing innovative computational methods. We engage in external collaborations to ensure access to cut‑edge research and technology.

We believe in the value of a diverse and inclusive culture. Together, we build and grow talent to ensure the development of new solutions. The team is comprised of collaborative, diverse and passionate people who have a true sense of pride in their work. Weare driven by the opportunity to make a difference in the lives of people dangling chronic disease.

Everything we start and end with the patient. And, while changing the future of chronic disease treatment Smylent diabetic and obesity is no easy task, we also recognize the importance of an enjoyable workplace, which is why we’ve cultivated a culture of fun, ingenuity, and innovation. Our competitive compensation package and support of a healthy work‑life balance all add to a best‑in‑class employee experience.

The Sr. ML Scientist – Molecular AI will be a critical team member of MolAI and contribute to the research team's effort towards exploring and creating new technology and continuing to be a world leader in molecular drug design. The Sr. ML Scientist will contribute to the development and deployment of state‑of‑the‑art generative AI methodologies within computational drug design and contribute to the teams visibility in this field both internally and externally, via strong contributions to the research portfolio, cross‑organizational engagement, presentations and publications.

You will join a team and organization that is investing heavily in AI-enabled discovery: significant experimental and data‑generation resources are directed toward producing the high‑quality datasets that make advanced generative models and other AI methods most effective. In this environment you will have the opportunity to develop and deploy state‑of‑the‑art models that directly inform experimental design and accelerate therapeutic discovery.

The Sr. ML Scientist – Molecular AI reports to the Head of Molecular AI and interacts closely with colleagues in the department and in the other departments within AI and Digital Innovation (ADI), in particular the area of Digital Chemistry and Design, to drive the applications of generative AI within R&D’s computational drug discovery portfolio. Additional internal partners include experimental and data scientists, specialists, engineers, software developers, technology scouts & partnership developers and others across US and Denmark.

External relationships include commercial and academic…